These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19892666)

  • 21. Advances in viral oncology research: summary of the 3rd International Meeting.
    Tornesello ML; Buonaguro L; Buonaguro FM
    Expert Rev Vaccines; 2012 Apr; 11(4):411-4. PubMed ID: 22551025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers.
    Follen M; Meyskens FL; Alvarez RD; Walker JL; Bell MC; Storthz KA; Sastry J; Roy K; Richards-Kortum R; Cornelison TL
    Cancer; 2003 Nov; 98(9 Suppl):2044-51. PubMed ID: 14603541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in cancer chemoprevention.
    Lippman SM; Hittelman WN; Lotan R; Pastorino U; Hong WK
    Cancer Cells; 1991 Feb; 3(2):59-65. PubMed ID: 1674206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MedGenMed Hematology/Oncology conference report--translational research: any danger lurking in its wake? Highlights from the 2003 annual meeting of the American Association for Cancer Research; July 11-14, 2003; Washington, DC.
    Mariani SM
    MedGenMed; 2003 Aug; 5(3):34. PubMed ID: 14600670
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular targets for cancer prevention: a meeting review of the third American Cancer Society-Schilling Research Conference.
    Willis DB; Colburn NH
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):972-8. PubMed ID: 12376494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Report on Second International Conference on Natural Products for Cancer Prevention and Therapy Held in Kayseri, Turkey, 8-11 November 2017.
    Yerer MB; Bishayee A
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evidence-based approach to cancer prevention clinical trials.
    Greenwald P; McDonald SS; Anderson DE
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do we make optimal use of the potential of cancer prevention?
    Greenwald P; Dunn BK
    Recent Results Cancer Res; 2009; 181():3-17. PubMed ID: 19213552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unprecedented opportunities and promise for cancer prevention research.
    Blackburn EH; Tlsty TD; Lippman SM
    Cancer Prev Res (Phila); 2010 Apr; 3(4):394-402. PubMed ID: 20354163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer prevention: major initiatives and looking into the future.
    Gotay CC
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):143-54. PubMed ID: 20384561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontiers in Cancer Prevention Research. Abstracts of the 4th AACR International Conference, October 30-November 2, 2005, Baltimore, Maryland, USA.
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 2):2681s-2811s. PubMed ID: 16315419
    [No Abstract]   [Full Text] [Related]  

  • 32. Focus on cancer prevention.
    Morant R
    Trends Mol Med; 2002 Jul; 8(7):315-7. PubMed ID: 12114106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontiers in cancer prevention research.
    Sabichi AL; Demierre MF; Hawk ET; Lerman CE; Lippman SM
    Cancer Res; 2003 Sep; 63(18):5649-55. PubMed ID: 14522879
    [No Abstract]   [Full Text] [Related]  

  • 34. Translational research in oncology research & development and its impact on early development in China: report of the 5th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at 2013 AACR Annual Meeting.
    Guan L; Dai Y; Luo R
    Chin J Cancer; 2013 Jul; 32(7):357-62. PubMed ID: 23823625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Cancer Prevention Research in the United States and China: the 2009 China--U.S. Forum on Frontiers of Cancer Research.
    Bode AM; Cao Y; Dong Z
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1630-7. PubMed ID: 21149335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the technicalities of discovering and applying protein biomarkers for cancer prevention.
    Kas K
    Eur J Cancer Prev; 2004 Oct; 13(5):437-46. PubMed ID: 15452457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The need for preventive drugs and vaccines in global cancer control: a challenge for public health and for industry.
    Vainio H
    Toxicol Ind Health; 2002 Mar; 18(2):84-90. PubMed ID: 12868797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I2 imaging: cancer biology and the tumor microenvironment.
    Sloane BF; Gillies RJ; Mohla S; Sogn JA; Menkens AE; Sullivan DC
    Cancer Res; 2006 Dec; 66(23):11097-9. PubMed ID: 17114235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer chemoprevention: progress and promise.
    Kelloff GJ; Sigman CC; Greenwald P
    Eur J Cancer; 1999 Dec; 35(13):1755-62. PubMed ID: 10673988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.